Citius Oncology, Inc.
CTOR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001851484
No open-market purchases or sales by Citius Oncology, Inc. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.20M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Citius Oncology, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 6
- −5 vs. Q4 2024
- Shares held
- 105.0K
- −95.9K (−47.7%) vs. Q4 2024
- Total value
- $97.7K
- −$132.5K (−57.6%) vs. Q4 2024
- New holders
- 0
- 2 more added
- Sold out
- 5
- 1 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CTOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $9.20M |
| Q1 2026 | 14 | $8.83M |
| Q4 2025 | 18 | $6.86M |
| Q3 2025 | 16 | $17.0M |
| Q2 2025 | 7 | $989.6K |
| Q1 2025 | 6 | $97.7K |
| Q4 2024 | 11 | $230.2K |
| Q3 2024 | 7 | $57.0K |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Citius Oncology, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 49,745 | $46.3K | 0.00% | +24,940+100.5% | Added |
| IFP Advisors, Inc | 22,215 | $20.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 20,539 | $19.1K | 0.00% | +7,888+62.4% | Added |
| Yakira Capital Management, Inc. | 11,999 | $11.2K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 350 | $325 | 0.00% | −5,130−93.6% | Reduced |
| Bank of America Corp | 160 | $149 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −68,543−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −22,699−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −21,095−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −11,196−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −41−100.0% | Sold out |